Investments by Venture Capital Firms in Health and Life Science Sector, 2005-06
Dublin February 16, 2006 -- Research and Markets (http://www.researchandmarkets.com/reports/c32853) has announced the addition of Venture Funding in Healthcare Industry (2006) - A Market
Study's8482; to their offering
This study on Venture Funding in Healthcare Industry (2006) - A Market Study's8482; provides an insight to the in-pharma research and role of venture capitalist in healthcare industry.
The survey shows an increase in venture funding reflecting brimming enthusiasm among the investors in the field of biotechnology, pharmaceuticals and heath services. The study presents
forth-assaying market opportunities in wake of successful initial public offering and number of mergers worldwide.
This report estimates the role of investors and growing technological imprints attracting large and small countries and new market opportunities. The report discusses current policies,
investors funding, sales ad demand ratio, and further investment areas.
The research, in association to its network of partners provides information and research to thousands of clients worldwide. The information provided herein has been obtained from
reliable sources to provide a holistic survey on the market dynamics.
Companies Mentioned:
- Jazz Pharmaceuticals, Inc.
- Esprit Pharma Holding Company (FKA: Saturn Pharmaceuticals, Inc.)
- Somaxon Pharmaceuticals, Inc.
- Idun Pharmaceuticals, Inc.
- Orexigen Therapeutics, Inc.
- Raven Biotechnologies, Inc.
- Therion Biologics Corporation
- Molecular Insight Pharmaceuticals, Inc.
- Verus Pharmaceuticals, Inc.
- Receptor Biologix, Inc.
- Anacor Pharmaceuticals, Inc.
- GlobeImmune, Inc.
- Ambrx, Inc.
- Orqis Medical Corporation
- Phenomix Corporation
- Ilypsa, Inc.
- Celator Pharmaceuticals, Inc. (FKA: Celator Technologies)
- Nephros Therapeutics, Inc.
- Tandem Labs
- Peptimmune, Inc.
- Avidia, Inc. (AKA: Avidia Research Institute, Inc.)
- Aureon Biosciences Corporation
- Cellerant Therapeutics, Inc.
- Cerexa, Inc.
- SomaLogic, Inc.
- Optimer Pharmaceuticals, Inc.
- AgraQuest, Inc.
- BioMimetic Pharmaceuticals Inc.
- Conforma Therapeutics Corporation
For more information visit http://www.researchandmarkets.com/reports/c32853
Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980